The Value of Combining Blood Culture and SeptiFast Data for Predicting Complicated Bloodstream Infections Caused by Gram-Positive Bacteria or Candida Species
Open Access
- 1 April 2013
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (4) , 1130-1136
Abstract
Management of complicated bloodstream infections requires more aggressive treatment than uncomplicated bloodstream infections. We assessed the value of follow-up blood culture in bloodstream infections caused by Staphylococcus aureus , Enterococcus spp., Streptococcus spp., and Candida spp. and studied the value of persistence of DNA in blood (using SeptiFast) for predicting complicated bloodstream infections. Patients with bloodstream infections caused by these microorganisms were enrolled prospectively. After the first positive blood culture, samples were obtained every third day to perform blood culture and SeptiFast analyses simultaneously. Patients were followed to detect complicated bloodstream infection. The study sample comprised 119 patients. One-third of the patients developed complicated bloodstream infections. The values of persistently positive tests to predict complicated bloodstream infections were as follows: SeptiFast positive samples (sensitivity, 56%; specificity, 79.5%; positive predictive value, 54%; negative predictive value, 80.5%; accuracy, 72.3%) and positive blood cultures (sensitivity, 30.5%; specificity, 92.8%; positive predictive value, 64%; negative predictive value, 75.5%; accuracy, 73.9%). Multivariate analysis showed that patients with a positive SeptiFast result between days 3 and 7 had an almost 8-fold-higher risk of developing a complicated bloodstream infection. In S. aureus , the combination of both techniques to exclude endovascular complications was significantly better than the use of blood culture alone. We obtained a score with variables selected by the multivariate model. With a cutoff of 7, the negative predictive value for complicated bloodstream infection was 96.6%. Patients with a positive SeptiFast result between days 3 and 7 after a positive blood culture have an almost 8-fold-higher risk of developing complicated bloodstream infections. A score combining clinical data with the SeptiFast result may improve the exclusion of complicated bloodstream infections.Keywords
This publication has 19 references indexed in Scilit:
- Risk Factors For Hematogenous Complications of Intravascular Catheter--Associated Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2005
- Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal DiseaseJournal of Clinical Microbiology, 2004
- Importance of aggressive evaluation in patients with Staphylococcus aureus bacteremiaAmerican Heart Journal, 2004
- Clinical Identifiers of Complicated Staphylococcus aureus BacteremiaArchives of internal medicine (1960), 2003
- A Prospective Multicenter Study of Staphylococcus aureus BacteremiaMedicine, 2003
- Meningococcal bacterial DNA load at presentation correlates with disease severityArchives of Disease in Childhood, 2002
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective EndocarditisClinical Infectious Diseases, 2000
- THE SEPSIS SYNDROMEClinics in Chest Medicine, 1996
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- Gram-negative bacteremiaDisease-a-Month, 1973